Home » Topics » BioWorld Science

BioWorld Science
RSS

Servier and Galapagos initiate phase II trial with S-201086 in osteoarthritis

June 27, 2018

FDA advisory committees recommend against approval of Remoxy ER

June 27, 2018

Pivot plans IND filing to begin clinical trials with PVT-005

June 27, 2018

Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis

June 27, 2018

Ensemble Therapeutics divulges IDO-1 inhibitors

June 27, 2018

Fraunhofer-Gesellschaft describes new bacterial glutaminyl cyclase inhibitors

June 27, 2018

Arcus Biosciences, Infinity Pharmaceuticals collaborate on studies of triple combination therapies

June 27, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Chugai describes OWL-833, an orally active non-peptide GLP-1 receptor agonist

June 27, 2018

In vivo evaluation of PD-L1-targeted PET imaging agent [64Cu]DK222

June 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...